相似文献
1
Studies on the selective lysis and purification of Trypanosoma cruzi.
J Exp Med. 1975 Jul 1;142(1):224-9. doi: 10.1084/jem.142.1.224.
2
Role of complement in immune lysis of Trypanosoma cruzi.
Infect Immun. 1972 Nov;6(5):860-4. doi: 10.1128/iai.6.5.860-864.1972.
3
Relative resistance of Brazil strain trypomastigote forms of Trypanosoma cruzi to in vitro antibody-dependent complement-mediated lysis.
J Parasitol. 1988 Dec;74(6):1046-50.
4
Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum.
Exp Parasitol. 1975 Aug;38(1):20-9. doi: 10.1016/0014-4894(75)90034-x.
5
Comparative studies on epimastigote and metacyclic stages of Trypanosoma cruzi. II. Selective lysis by rodent sera.
Int J Zoonoses. 1985 Dec;12(4):323-30.
6
7
Differentiation between Trypanosoma cruzi and T. rangeli by their different complement sensitivity.
Tropenmed Parasitol. 1982 Sep;33(3):147-50.
8
Binding of antibody and resistance to lysis of trypomastigotes of Trypanosoma cruzi.
Parasite Immunol. 1992 Jan;14(1):1-12. doi: 10.1111/j.1365-3024.1992.tb00001.x.
9
Lysis of vector-transmissible, metacyclic forms of Trypanosoma cruzi by avian serum.
J Parasitol. 1984 Feb;70(1):155-6.
10
Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages.
Proc Natl Acad Sci U S A. 1981 Jan;78(1):602-5. doi: 10.1073/pnas.78.1.602.
引用本文的文献
1
Infectivity of Aflagellar Epimastigotes of in the DH82 Cell Line and Mouse Peritoneal Macrophages.
J Parasitol Res. 2025 Mar 7;2025:7057514. doi: 10.1155/japr/7057514. eCollection 2025.
2
Interaction of , Triatomines and the Microbiota of the Vectors-A Review.
Microorganisms. 2024 Apr 25;12(5):855. doi: 10.3390/microorganisms12050855.
3
Mechanisms by which Factor H protects from the alternative pathway of complement.
Front Immunol. 2024 Feb 1;15:1152000. doi: 10.3389/fimmu.2024.1152000. eCollection 2024.
4
An induced population of epimastigotes more resistant to complement lysis promotes a phenotype with greater differentiation, invasiveness, and release of extracellular vesicles.
Front Cell Infect Microbiol. 2022 Dec 14;12:1046681. doi: 10.3389/fcimb.2022.1046681. eCollection 2022.
5
Parasitomimetics: Can We Utilize Parasite-Derived Immunomodulatory Molecules for Interventions to Immunological Disorders?
Front Immunol. 2022 Mar 21;13:824695. doi: 10.3389/fimmu.2022.824695. eCollection 2022.
6
Overview of the role of kinetoplastid surface carbohydrates in infection and host cell invasion: prospects for therapeutic intervention.
Parasitology. 2019 Dec;146(14):1743-1754. doi: 10.1017/S0031182019001355. Epub 2019 Oct 11.
7
Complement system contributes to modulate the infectivity of susceptible TcI strains of Trypanosoma cruzi.
Mem Inst Oswaldo Cruz. 2018 Feb 19;113(4):e170332. doi: 10.1590/0074-02760170332.
8
The Complement System: A Prey of .
Front Microbiol. 2017 Apr 20;8:607. doi: 10.3389/fmicb.2017.00607. eCollection 2017.
9
The Trypanosoma cruzi Diamine Transporter Is Essential for Robust Infection of Mammalian Cells.
PLoS One. 2016 Apr 6;11(4):e0152715. doi: 10.1371/journal.pone.0152715. eCollection 2016.
10
Golgi UDP-GlcNAc:polypeptide O-α-N-Acetyl-d-glucosaminyltransferase 2 (TcOGNT2) regulates trypomastigote production and function in Trypanosoma cruzi.
Eukaryot Cell. 2014 Oct;13(10):1312-27. doi: 10.1128/EC.00165-14. Epub 2014 Aug 1.
本文引用的文献
1
Cultural and physiological observations on Trypanosoma rhodesiense and Trypanosoma gambiense.
J Parasitol. 1950 Feb;36(1):48-54.
2
Stearic acid, an essential growth factor for Trypanosoma cruzi.
J Gen Microbiol. 1963 May;31:261-6. doi: 10.1099/00221287-31-2-261.
3
Comparative bactericidal activities of blood serum and plasma serum.
J Exp Med. 1960 Jul 1;112(1):15-22. doi: 10.1084/jem.112.1.15.
4
[Lytic effect of normal sera on cultured and sanguineous forms of Trypanosoma cruzi].
Bol Chil Parasitol. 1956 Oct-Dec;11(4):62-9.
5
The properdin system and immunity. III. The zymosan assay of properdin.
J Exp Med. 1956 Jan 1;103(1):1-13. doi: 10.1084/jem.103.1.1.
6
The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.
Science. 1954 Aug 20;120(3112):279-85. doi: 10.1126/science.120.3112.279.
7
Role of complement in immune lysis of Trypanosoma cruzi.
Infect Immun. 1972 Nov;6(5):860-4. doi: 10.1128/iai.6.5.860-864.1972.
8
The C3-activator system: an alternate pathway of complement activation.
J Exp Med. 1971 Sep 1;134(3 Pt 2):90s-108s.
9
Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi.
Infect Immun. 1975 Jan;11(1):86-91. doi: 10.1128/iai.11.1.86-91.1975.
Zotero 插件